Liquidia Technologies Inc

NASDAQ:LQDA   3:24:25 PM EDT
4.44
-0.10 (-2.31%)
Products

Liquidia Provides Update On U.S. Patent Trial And Appeal Board Decision On Inter Partes Review Of Two United Therapeutics’ Tyvaso® Patents

Published: 10/14/2020 15:05 GMT
Liquidia Technologies Inc (LQDA) - Liquidia Provides Update on U.S. Patent Trial and Appeal Board Decision on Inter Partes Review of Two United Therapeutics’ Tyvaso® Patents.
Liquidia Technologies - U.S. Ptab Has Instituted Ipr Against U.S. Patent No. 9,604,901 ('901), Concurrently Denied Institution on 9,593,066 ('066).